PPP1R1B
PPP1R1B (protein phosphatase 1 regulatory inhibitor subunit 1B, also known as DARPP-32) is a cytoplasmic inhibitor of protein phosphatase 1. It is described as a bifunctional signal transduction molecule whose activity is regulated by dopaminergic and glutamatergic receptor stimulation. Browse Assay Genie's current range of PPP1R1B research reagents below, or read on for the biology behind the target.
PPP1R1B functions as an inhibitor of protein phosphatase 1. The NCBI Gene summary describes the protein as a bifunctional signal transduction molecule: depending on its phosphorylation state, it can act as a kinase inhibitor or as a phosphatase inhibitor. That phosphorylation and function are regulated by stimulation of dopaminergic and glutamatergic receptors, which places PPP1R1B at the point where neurotransmitter signals are converted into changes in protein phosphorylation.
The PPP1R1B gene encodes a protein of the protein phosphatase inhibitor 1 family and belongs to the HGNC group of protein phosphatase 1 regulatory subunits. UniProt places the protein in the cytoplasm. Multiple transcript variants encoding different isoforms have been reported for the gene. Mouse and rat orthologs, both named Ppp1r1b, are also annotated, which allows the pathway to be studied in common rodent models.
The protein is widely known as DARPP-32, and the gene has also been listed under the symbol FLJ20940. The previous HGNC name was protein phosphatase 1, regulatory (inhibitor) subunit 1B. Because PPP1R1B is a target for dopamine, the NCBI Gene summary notes that it may serve as a therapeutic target for neurologic and psychiatric disorders. Researchers studying PPP1R1B often place it alongside the PP1 catalytic subunits and other PP1 regulators, so that changes in its phosphorylation can be read in the context of wider phosphatase control.
PPP1R1B is a dopamine target whose phosphorylation and function as a kinase or phosphatase inhibitor are regulated by dopaminergic receptor stimulation.
Glutamatergic receptor stimulation also regulates PPP1R1B, making it relevant to studies of how excitatory signals alter protein phosphorylation.
As an inhibitor of protein phosphatase 1 in the inhibitor 1 family, PPP1R1B is a model regulator for studying PP1 control.
Because it is a dopamine target, PPP1R1B may serve as a therapeutic target for neurologic and psychiatric disorders.
PPP1R1B inhibits protein phosphatase 1. It is described as a bifunctional signal transduction molecule that can act as a kinase or phosphatase inhibitor, with its phosphorylation and function regulated by dopaminergic and glutamatergic receptor stimulation.
Yes. DARPP-32 is an alias for PPP1R1B. The gene has also been listed as FLJ20940, and its earlier HGNC name was protein phosphatase 1, regulatory (inhibitor) subunit 1B. Multiple transcript variants encoding different isoforms have been found.
Mouse and rat orthologs, both named Ppp1r1b, are annotated. The human protein belongs to the protein phosphatase inhibitor 1 family. Check the datasheet of any product for its validated reactivity.
Other protein phosphatase 1 regulatory subunits, PP1 catalytic subunits and related phosphatases with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9UD71; product specifications from Assay Genie datasheets.